CUBT Stock - Curative Biotechnology, Inc.
Unlock GoAI Insights for CUBT
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | $-92,213 | $-97,515 | $-7,955 | $-6,744 | $-5,301 |
| Gross Margin | N/A | N/A | N/A | N/A | N/A |
| Operating Income | $-2,441,000 | $-1,933,000 | $-4,467,000 | $-5,014,000 | $-4,636,000 |
| Net Income | $-3,565,000 | $-3,957,000 | $-5,380,000 | $-5,340,000 | $-4,670,000 |
| Net Margin | N/A | N/A | N/A | N/A | N/A |
| EPS | $-0.00 | $-0.01 | $-0.01 | $-0.04 | $-0.01 |
Curative Biotechnology, Inc. operates as a development-stage biomedical company. The company develops pipeline focusing on therapeutic areas, such as infectious diseases, oncology, and degenerative eye disease. Its pipeline candidates include IMT504, a novel immune therapy to treat rabies and an adjuvant for vaccines; CUBT906, a fully humanized CD56 monoclonal antibody carrying a pyrrolobenzodiazepine dimer directly to the tumor site to kill the tumor by inhibiting tumor growth and migration of the tumor; and Metformin Reformulation for the treatment of degenerative eye disease. The company has a licensing and co-development agreement with Mid-Atlantic BioTherapeutics, Inc. to develop IMT504 to treat late-stage rabies and COVID-19 vaccine. The company was formerly known as Connectyx Technologies Holdings Group, Inc. and changed its name to Curative Biotechnology, Inc. in November 2020. Curative Biotechnology, Inc. was founded in 1995 and is headquartered in Boca Raton, Florida.
Visit WebsiteEarnings History & Surprises
CUBTEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2025 | Nov 14, 2025 | — | — | — | — |
Q3 2025 | Aug 14, 2025 | — | — | — | — |
Q3 2024 | Aug 11, 2024 | — | $-0.00 | — | — |
Q2 2024 | May 15, 2024 | — | $-0.00 | — | — |
Q1 2024 | Mar 28, 2024 | — | $-0.00 | — | — |
Q1 2024 | Jan 1, 2024 | — | $-0.00 | — | — |
Q3 2023 | Aug 14, 2023 | — | $-0.00 | — | — |
Q2 2023 | May 19, 2023 | — | $-0.00 | — | — |
Q4 2022 | Dec 31, 2022 | — | $-0.00 | — | — |
Q3 2022 | Sep 30, 2022 | — | $-0.00 | — | — |
Q2 2022 | Jun 30, 2022 | — | $-0.38 | — | — |
Q1 2022 | Mar 31, 2022 | — | $-0.00 | — | — |
Q4 2021 | Dec 31, 2021 | — | $-0.00 | — | — |
Q3 2021 | Sep 30, 2021 | — | $-0.30 | — | — |
Q2 2021 | Jun 30, 2021 | — | $-0.77 | — | — |
Q2 2021 | May 25, 2021 | — | $-0.20 | — | — |
Q1 2020 | Mar 31, 2020 | — | $0.00 | — | — |
Latest News
Frequently Asked Questions about CUBT
What is CUBT's current stock price?
What is the analyst price target for CUBT?
What sector is Curative Biotechnology, Inc. in?
What is CUBT's market cap?
Does CUBT pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to CUBT for comparison